Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.4.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LP.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.50.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.81NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBL.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.28.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.20.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.110NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.86.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.8.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.89NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HP.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCF.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JC.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.105NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.9.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.103NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HC.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FE.1.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.94NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-17749.7US
GK.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used